CancerCenter.ai
Valuation
$2M
2025 Revenue
$660K
Funding
$0
Team
6
Founded
2017
How CancerCenter.ai grew CancerCenter.ai to $660K revenue with a 6 person team in 2025.
CancerCenter.ai - Web Platform for Digital pathology & Radiology with Artificial Intelligence With the help of AI, our CancerCenterAI web platform assists pathologists and radiologists/oncologists in making faster and more accurate diagnoses through specialized modules. Our web platform offers an intuitive file browser and viewers for pathology and also radiology data. Features: - PathoCam: save pathology/microscope images by using your own microscope equipment. - PathoViewer Module: web viewer for telepathology to analyze, annotate and comment cases. - Laboratory Information System Module - RadioViewer Module: DICOM web viewer to analyze Radiology images (MRI, CT, USG others) with PACS integration - Advanced AI Algorithms i.e: Gleason score, ki67, Metastasis, etc - Collaborative and Remote Diagnostics: The sharing features of our platform allow for easy and secure collaboration with colleagues, whether they are in the next room or another country, fostering a more effective and interactive diagnostic process - Accelerated and Standardized Reporting: With integrated ICCR, WHO or custom report templates - Robust Security: Our platform employs SSL encryption and other cutting-edge security measures to ensure the privacy and integrity of your sensitive data. - Scanner Integration Options: Our platform can integrate with any scanner, ensuring that your existing equipment is part of your streamlined, digital workflow, thereby saving costs and avoiding the hassle of changing hardware. More details about us and our products: https://cancercenter.ai Feel free to contact us: Piotr Krajewski + 48 694 233 234, [email protected] Let’s save lives!
Last updated
CancerCenter.ai Revenue
In 2025, CancerCenter.ai's revenue reached $660K. Since its launch in 2017, CancerCenter.ai has shown consistent revenue growth.
| Year | Milestone |
|---|---|
| 2025 | CancerCenter.ai Hit $660k revenue in September 2025 |
| 2017 | Launched with $0 revenue |
CancerCenter.ai Valuation, Funding Rounds
CancerCenter.ai's most recent disclosed valuation is $2M.
CancerCenter.ai is a bootstrapped Other Collaboration Software startup. Founded in 2017, CancerCenter.ai has grown to $660K in revenue without raising any venture capital or outside funding.
As a self-funded Other Collaboration Software SaaS company, CancerCenter.ai has built its business with no outside investment.
| Year | Round | Amount | Valuation | % Sold |
|---|
CancerCenter.ai Employees & Team Size
CancerCenter.ai employs approximately 6 people as of 2026.
CancerCenter.ai has 6 total employees in different roles and functions.
| Year | Milestone |
|---|---|
| 2025 | Reached 6 employees (September 2025) |
Customers
We do not have customer count information for CancerCenter.ai yet.
Frequently Asked Questions about CancerCenter.ai
What is CancerCenter.ai's revenue?
CancerCenter.ai generates $660K in revenue.
How much funding does CancerCenter.ai have?
CancerCenter.ai raised $0.
How many employees does CancerCenter.ai have?
CancerCenter.ai has 6 employees.
Where is CancerCenter.ai headquarters?
CancerCenter.ai is headquartered in Wrocław, Dolnośląskie, Poland.
People Also Viewed
DoxyChain
Next-generation blockchain document management system (DMS)
Treatstock
The company primarily operates in the Software industry. Treatstock was founded in 2016 and is headquartered in Newark, DE.
Webproof
The company primarily operates in the Software industry. Webproof is headquartered in Miami, FL.
Echelon Insights
Provider of digital intelligence intended to offer research and analytics services. The company's intelligence provides complete situational awareness by creating and organizing the information needed to make the best decisions, enabling companies to make informed decision that helps improve their businesses.
OpsVantage Digital
X-CITE S.A.
We merged the IoT & AI SYSTEM ENABLER and DESIGN HOUSE view, creating a unique positioning to enable private and public clients ’cross industries to deploy IoT, AI & 5G solutions in a reliable way, “Out of the Box”. Regrouping multiple expertise – IoT, Cloud technologies, Mass data, AI, ML, Security, NG telco networks incl. 5G & xPON, automatization - our offer is unique! From idea generation, over fast prototypes, POCs’, followed by large implementations using X-BRAiN as a Connectivity, Mass-data and AI Accelerator incl. NEF-SCEF 5G integration. X-CITE is official Google Cloud partner. Our aim is to build a library of +200 AI & 5G use cases covering the most essential verticals, allowing our multi-disciplinary teams together with customers to rapidly formulate ideas or use-cases and implement them in X-BRAiN with low TTM. X-BRAiN uses ML and AI algorithms to address IoT and its associated problems, all available in a subscription model. Our Foundational Technology Platform is blockchain enabled. Learn more on www.x-brain.io Our offer includes a growing Edge hardware portfolio integr. with X-BRAiN and available in subscription model. It includes a world first advanced 5G Google Coral Module which can be mounted straight on devices including Drones; modular 4G LTE Cat. M1/Cat. NB2/EGPRS & GNSS high-speed Tracker and environmental Sensor, NB1/NB2 and M1 cellular LPWAN vehicle and health tracker. We are accelerating our move to a Digital Business Platform model and open-up X-BRAiN to developers that can make more of the data, assets, and services available – Become part of our “Firestarters” developer community. We design and build your future IoT, AI, 5G and circular economy strategy and products. X-CITE is headquartered in Luxembourg, with offices in Munich and Belgrade and strong links to UK.
Compare CancerCenter.ai to the industry
CancerCenter.ai operates across multiple industries. Browse revenue, funding, and growth data for CancerCenter.ai in each sector below.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .